nodes	percent_of_prediction	percent_of_DWPC	metapath
Tramadol—HTR2C—Sorafenib—liver cancer	0.186	0.359	CbGbCtD
Tramadol—CYP2B6—Sorafenib—liver cancer	0.116	0.223	CbGbCtD
Tramadol—CYP2B6—Doxorubicin—liver cancer	0.0701	0.135	CbGbCtD
Tramadol—CYP2D6—Sorafenib—liver cancer	0.0558	0.108	CbGbCtD
Tramadol—CYP3A4—Sorafenib—liver cancer	0.0355	0.0684	CbGbCtD
Tramadol—CYP2D6—Doxorubicin—liver cancer	0.0339	0.0653	CbGbCtD
Tramadol—CYP3A4—Doxorubicin—liver cancer	0.0215	0.0415	CbGbCtD
Tramadol—Alanine aminotransferase increased—Epirubicin—liver cancer	0.000384	0.00098	CcSEcCtD
Tramadol—Muscular weakness—Epirubicin—liver cancer	0.000384	0.00098	CcSEcCtD
Tramadol—Dizziness—Sorafenib—liver cancer	0.000383	0.000977	CcSEcCtD
Tramadol—Mood swings—Doxorubicin—liver cancer	0.000382	0.000974	CcSEcCtD
Tramadol—Abdominal distension—Epirubicin—liver cancer	0.000379	0.000967	CcSEcCtD
Tramadol—Ataxia—Doxorubicin—liver cancer	0.000379	0.000967	CcSEcCtD
Tramadol—Blood creatinine increased—Doxorubicin—liver cancer	0.000378	0.000963	CcSEcCtD
Tramadol—Influenza—Epirubicin—liver cancer	0.000377	0.00096	CcSEcCtD
Tramadol—Dysphagia—Epirubicin—liver cancer	0.000377	0.00096	CcSEcCtD
Tramadol—Asthma—Epirubicin—liver cancer	0.000377	0.00096	CcSEcCtD
Tramadol—Dehydration—Doxorubicin—liver cancer	0.000375	0.000956	CcSEcCtD
Tramadol—Liver function test abnormal—Doxorubicin—liver cancer	0.000372	0.000949	CcSEcCtD
Tramadol—Dry skin—Doxorubicin—liver cancer	0.00037	0.000942	CcSEcCtD
Tramadol—Pancreatitis—Epirubicin—liver cancer	0.000369	0.000941	CcSEcCtD
Tramadol—Vomiting—Sorafenib—liver cancer	0.000368	0.000939	CcSEcCtD
Tramadol—Abdominal pain upper—Doxorubicin—liver cancer	0.000368	0.000939	CcSEcCtD
Tramadol—Orthostatic hypotension—Doxorubicin—liver cancer	0.000368	0.000939	CcSEcCtD
Tramadol—Hypokalaemia—Doxorubicin—liver cancer	0.000367	0.000936	CcSEcCtD
Tramadol—Angina pectoris—Epirubicin—liver cancer	0.000367	0.000935	CcSEcCtD
Tramadol—Rash—Sorafenib—liver cancer	0.000365	0.000932	CcSEcCtD
Tramadol—Dermatitis—Sorafenib—liver cancer	0.000365	0.000931	CcSEcCtD
Tramadol—Breast disorder—Doxorubicin—liver cancer	0.000364	0.000929	CcSEcCtD
Tramadol—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.000363	0.000926	CcSEcCtD
Tramadol—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000363	0.000926	CcSEcCtD
Tramadol—Headache—Sorafenib—liver cancer	0.000363	0.000926	CcSEcCtD
Tramadol—Bronchitis—Epirubicin—liver cancer	0.000362	0.000923	CcSEcCtD
Tramadol—Nasopharyngitis—Doxorubicin—liver cancer	0.000361	0.000919	CcSEcCtD
Tramadol—Gastritis—Doxorubicin—liver cancer	0.000357	0.00091	CcSEcCtD
Tramadol—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000356	0.000907	CcSEcCtD
Tramadol—Muscular weakness—Doxorubicin—liver cancer	0.000356	0.000907	CcSEcCtD
Tramadol—Dysuria—Epirubicin—liver cancer	0.000352	0.000898	CcSEcCtD
Tramadol—Abdominal distension—Doxorubicin—liver cancer	0.000351	0.000894	CcSEcCtD
Tramadol—Upper respiratory tract infection—Epirubicin—liver cancer	0.00035	0.000892	CcSEcCtD
Tramadol—Influenza—Doxorubicin—liver cancer	0.000348	0.000888	CcSEcCtD
Tramadol—Asthma—Doxorubicin—liver cancer	0.000348	0.000888	CcSEcCtD
Tramadol—Dysphagia—Doxorubicin—liver cancer	0.000348	0.000888	CcSEcCtD
Tramadol—Pollakiuria—Epirubicin—liver cancer	0.000348	0.000887	CcSEcCtD
Tramadol—Nausea—Sorafenib—liver cancer	0.000344	0.000878	CcSEcCtD
Tramadol—Photosensitivity reaction—Epirubicin—liver cancer	0.000344	0.000876	CcSEcCtD
Tramadol—Pancreatitis—Doxorubicin—liver cancer	0.000342	0.000871	CcSEcCtD
Tramadol—Weight decreased—Epirubicin—liver cancer	0.000341	0.000869	CcSEcCtD
Tramadol—Hyperglycaemia—Epirubicin—liver cancer	0.00034	0.000866	CcSEcCtD
Tramadol—Angina pectoris—Doxorubicin—liver cancer	0.000339	0.000865	CcSEcCtD
Tramadol—Pneumonia—Epirubicin—liver cancer	0.000338	0.000861	CcSEcCtD
Tramadol—Infestation NOS—Epirubicin—liver cancer	0.000336	0.000856	CcSEcCtD
Tramadol—Infestation—Epirubicin—liver cancer	0.000336	0.000856	CcSEcCtD
Tramadol—Bronchitis—Doxorubicin—liver cancer	0.000335	0.000854	CcSEcCtD
Tramadol—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000333	0.000849	CcSEcCtD
Tramadol—Renal failure—Epirubicin—liver cancer	0.00033	0.000842	CcSEcCtD
Tramadol—Stomatitis—Epirubicin—liver cancer	0.000327	0.000835	CcSEcCtD
Tramadol—Conjunctivitis—Epirubicin—liver cancer	0.000326	0.000832	CcSEcCtD
Tramadol—Urinary tract infection—Epirubicin—liver cancer	0.000326	0.000832	CcSEcCtD
Tramadol—Dysuria—Doxorubicin—liver cancer	0.000326	0.000831	CcSEcCtD
Tramadol—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000324	0.000826	CcSEcCtD
Tramadol—Sweating—Epirubicin—liver cancer	0.000322	0.000821	CcSEcCtD
Tramadol—Pollakiuria—Doxorubicin—liver cancer	0.000322	0.000821	CcSEcCtD
Tramadol—Haematuria—Epirubicin—liver cancer	0.00032	0.000816	CcSEcCtD
Tramadol—Photosensitivity reaction—Doxorubicin—liver cancer	0.000318	0.000811	CcSEcCtD
Tramadol—Hepatobiliary disease—Epirubicin—liver cancer	0.000318	0.00081	CcSEcCtD
Tramadol—Epistaxis—Epirubicin—liver cancer	0.000317	0.000808	CcSEcCtD
Tramadol—Weight decreased—Doxorubicin—liver cancer	0.000315	0.000804	CcSEcCtD
Tramadol—Sinusitis—Epirubicin—liver cancer	0.000315	0.000803	CcSEcCtD
Tramadol—Hyperglycaemia—Doxorubicin—liver cancer	0.000314	0.000801	CcSEcCtD
Tramadol—Pneumonia—Doxorubicin—liver cancer	0.000313	0.000797	CcSEcCtD
Tramadol—Infestation NOS—Doxorubicin—liver cancer	0.000311	0.000792	CcSEcCtD
Tramadol—Infestation—Doxorubicin—liver cancer	0.000311	0.000792	CcSEcCtD
Tramadol—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000308	0.000785	CcSEcCtD
Tramadol—Bradycardia—Epirubicin—liver cancer	0.000307	0.000782	CcSEcCtD
Tramadol—Renal failure—Doxorubicin—liver cancer	0.000305	0.000779	CcSEcCtD
Tramadol—Haemoglobin—Epirubicin—liver cancer	0.000303	0.000772	CcSEcCtD
Tramadol—Stomatitis—Doxorubicin—liver cancer	0.000303	0.000772	CcSEcCtD
Tramadol—Rhinitis—Epirubicin—liver cancer	0.000302	0.000771	CcSEcCtD
Tramadol—Urinary tract infection—Doxorubicin—liver cancer	0.000302	0.00077	CcSEcCtD
Tramadol—Conjunctivitis—Doxorubicin—liver cancer	0.000302	0.00077	CcSEcCtD
Tramadol—Haemorrhage—Epirubicin—liver cancer	0.000301	0.000769	CcSEcCtD
Tramadol—Hepatitis—Epirubicin—liver cancer	0.000301	0.000769	CcSEcCtD
Tramadol—Hypoaesthesia—Epirubicin—liver cancer	0.0003	0.000765	CcSEcCtD
Tramadol—Pharyngitis—Epirubicin—liver cancer	0.000299	0.000763	CcSEcCtD
Tramadol—Sweating—Doxorubicin—liver cancer	0.000298	0.000759	CcSEcCtD
Tramadol—Urinary tract disorder—Epirubicin—liver cancer	0.000298	0.000759	CcSEcCtD
Tramadol—Oedema peripheral—Epirubicin—liver cancer	0.000297	0.000757	CcSEcCtD
Tramadol—Haematuria—Doxorubicin—liver cancer	0.000296	0.000755	CcSEcCtD
Tramadol—Connective tissue disorder—Epirubicin—liver cancer	0.000296	0.000755	CcSEcCtD
Tramadol—Urethral disorder—Epirubicin—liver cancer	0.000296	0.000753	CcSEcCtD
Tramadol—Hepatobiliary disease—Doxorubicin—liver cancer	0.000294	0.000749	CcSEcCtD
Tramadol—Epistaxis—Doxorubicin—liver cancer	0.000293	0.000747	CcSEcCtD
Tramadol—Sinusitis—Doxorubicin—liver cancer	0.000292	0.000743	CcSEcCtD
Tramadol—Visual impairment—Epirubicin—liver cancer	0.000291	0.000741	CcSEcCtD
Tramadol—Erythema multiforme—Epirubicin—liver cancer	0.000285	0.000727	CcSEcCtD
Tramadol—Bradycardia—Doxorubicin—liver cancer	0.000284	0.000724	CcSEcCtD
Tramadol—Eye disorder—Epirubicin—liver cancer	0.000282	0.000718	CcSEcCtD
Tramadol—Tinnitus—Epirubicin—liver cancer	0.000281	0.000717	CcSEcCtD
Tramadol—Haemoglobin—Doxorubicin—liver cancer	0.00028	0.000715	CcSEcCtD
Tramadol—Flushing—Epirubicin—liver cancer	0.00028	0.000713	CcSEcCtD
Tramadol—Cardiac disorder—Epirubicin—liver cancer	0.00028	0.000713	CcSEcCtD
Tramadol—Rhinitis—Doxorubicin—liver cancer	0.00028	0.000713	CcSEcCtD
Tramadol—Haemorrhage—Doxorubicin—liver cancer	0.000279	0.000711	CcSEcCtD
Tramadol—Hepatitis—Doxorubicin—liver cancer	0.000279	0.000711	CcSEcCtD
Tramadol—Hypoaesthesia—Doxorubicin—liver cancer	0.000278	0.000708	CcSEcCtD
Tramadol—Pharyngitis—Doxorubicin—liver cancer	0.000277	0.000706	CcSEcCtD
Tramadol—Urinary tract disorder—Doxorubicin—liver cancer	0.000275	0.000702	CcSEcCtD
Tramadol—Oedema peripheral—Doxorubicin—liver cancer	0.000275	0.000701	CcSEcCtD
Tramadol—Connective tissue disorder—Doxorubicin—liver cancer	0.000274	0.000699	CcSEcCtD
Tramadol—Angiopathy—Epirubicin—liver cancer	0.000274	0.000697	CcSEcCtD
Tramadol—Urethral disorder—Doxorubicin—liver cancer	0.000273	0.000697	CcSEcCtD
Tramadol—Immune system disorder—Epirubicin—liver cancer	0.000272	0.000694	CcSEcCtD
Tramadol—Mediastinal disorder—Epirubicin—liver cancer	0.000272	0.000693	CcSEcCtD
Tramadol—Chills—Epirubicin—liver cancer	0.000271	0.00069	CcSEcCtD
Tramadol—Arrhythmia—Epirubicin—liver cancer	0.000269	0.000687	CcSEcCtD
Tramadol—Visual impairment—Doxorubicin—liver cancer	0.000269	0.000685	CcSEcCtD
Tramadol—Mental disorder—Epirubicin—liver cancer	0.000264	0.000673	CcSEcCtD
Tramadol—Erythema multiforme—Doxorubicin—liver cancer	0.000264	0.000672	CcSEcCtD
Tramadol—Erythema—Epirubicin—liver cancer	0.000262	0.000669	CcSEcCtD
Tramadol—Malnutrition—Epirubicin—liver cancer	0.000262	0.000669	CcSEcCtD
Tramadol—Eye disorder—Doxorubicin—liver cancer	0.000261	0.000665	CcSEcCtD
Tramadol—Tinnitus—Doxorubicin—liver cancer	0.00026	0.000663	CcSEcCtD
Tramadol—Flushing—Doxorubicin—liver cancer	0.000259	0.00066	CcSEcCtD
Tramadol—Cardiac disorder—Doxorubicin—liver cancer	0.000259	0.00066	CcSEcCtD
Tramadol—Flatulence—Epirubicin—liver cancer	0.000259	0.000659	CcSEcCtD
Tramadol—Tension—Epirubicin—liver cancer	0.000258	0.000657	CcSEcCtD
Tramadol—Dysgeusia—Epirubicin—liver cancer	0.000257	0.000655	CcSEcCtD
Tramadol—Nervousness—Epirubicin—liver cancer	0.000255	0.00065	CcSEcCtD
Tramadol—Back pain—Epirubicin—liver cancer	0.000254	0.000647	CcSEcCtD
Tramadol—Angiopathy—Doxorubicin—liver cancer	0.000253	0.000645	CcSEcCtD
Tramadol—Muscle spasms—Epirubicin—liver cancer	0.000252	0.000643	CcSEcCtD
Tramadol—Immune system disorder—Doxorubicin—liver cancer	0.000252	0.000642	CcSEcCtD
Tramadol—Mediastinal disorder—Doxorubicin—liver cancer	0.000251	0.000641	CcSEcCtD
Tramadol—Chills—Doxorubicin—liver cancer	0.00025	0.000638	CcSEcCtD
Tramadol—Arrhythmia—Doxorubicin—liver cancer	0.000249	0.000635	CcSEcCtD
Tramadol—Vision blurred—Epirubicin—liver cancer	0.000247	0.000631	CcSEcCtD
Tramadol—Mental disorder—Doxorubicin—liver cancer	0.000244	0.000623	CcSEcCtD
Tramadol—Ill-defined disorder—Epirubicin—liver cancer	0.000243	0.000621	CcSEcCtD
Tramadol—Erythema—Doxorubicin—liver cancer	0.000243	0.000619	CcSEcCtD
Tramadol—Malnutrition—Doxorubicin—liver cancer	0.000243	0.000619	CcSEcCtD
Tramadol—Anaemia—Epirubicin—liver cancer	0.000243	0.000618	CcSEcCtD
Tramadol—Agitation—Epirubicin—liver cancer	0.000241	0.000615	CcSEcCtD
Tramadol—Flatulence—Doxorubicin—liver cancer	0.000239	0.00061	CcSEcCtD
Tramadol—Tension—Doxorubicin—liver cancer	0.000238	0.000607	CcSEcCtD
Tramadol—Dysgeusia—Doxorubicin—liver cancer	0.000238	0.000606	CcSEcCtD
Tramadol—Malaise—Epirubicin—liver cancer	0.000237	0.000603	CcSEcCtD
Tramadol—Nervousness—Doxorubicin—liver cancer	0.000236	0.000601	CcSEcCtD
Tramadol—Vertigo—Epirubicin—liver cancer	0.000236	0.000601	CcSEcCtD
Tramadol—Syncope—Epirubicin—liver cancer	0.000235	0.0006	CcSEcCtD
Tramadol—Back pain—Doxorubicin—liver cancer	0.000235	0.000599	CcSEcCtD
Tramadol—Muscle spasms—Doxorubicin—liver cancer	0.000233	0.000595	CcSEcCtD
Tramadol—Palpitations—Epirubicin—liver cancer	0.000232	0.000591	CcSEcCtD
Tramadol—Loss of consciousness—Epirubicin—liver cancer	0.000231	0.000588	CcSEcCtD
Tramadol—Cough—Epirubicin—liver cancer	0.000229	0.000584	CcSEcCtD
Tramadol—Vision blurred—Doxorubicin—liver cancer	0.000229	0.000583	CcSEcCtD
Tramadol—Convulsion—Epirubicin—liver cancer	0.000227	0.00058	CcSEcCtD
Tramadol—Hypertension—Epirubicin—liver cancer	0.000227	0.000578	CcSEcCtD
Tramadol—Ill-defined disorder—Doxorubicin—liver cancer	0.000225	0.000574	CcSEcCtD
Tramadol—Anaemia—Doxorubicin—liver cancer	0.000224	0.000572	CcSEcCtD
Tramadol—Arthralgia—Epirubicin—liver cancer	0.000223	0.00057	CcSEcCtD
Tramadol—Chest pain—Epirubicin—liver cancer	0.000223	0.00057	CcSEcCtD
Tramadol—Myalgia—Epirubicin—liver cancer	0.000223	0.00057	CcSEcCtD
Tramadol—Agitation—Doxorubicin—liver cancer	0.000223	0.000569	CcSEcCtD
Tramadol—Anxiety—Epirubicin—liver cancer	0.000223	0.000568	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000222	0.000566	CcSEcCtD
Tramadol—Discomfort—Epirubicin—liver cancer	0.000221	0.000563	CcSEcCtD
Tramadol—Malaise—Doxorubicin—liver cancer	0.000219	0.000558	CcSEcCtD
Tramadol—Dry mouth—Epirubicin—liver cancer	0.000219	0.000557	CcSEcCtD
Tramadol—Vertigo—Doxorubicin—liver cancer	0.000218	0.000556	CcSEcCtD
Tramadol—Syncope—Doxorubicin—liver cancer	0.000218	0.000555	CcSEcCtD
Tramadol—Confusional state—Epirubicin—liver cancer	0.000216	0.000551	CcSEcCtD
Tramadol—Palpitations—Doxorubicin—liver cancer	0.000215	0.000547	CcSEcCtD
Tramadol—Anaphylactic shock—Epirubicin—liver cancer	0.000214	0.000546	CcSEcCtD
Tramadol—Loss of consciousness—Doxorubicin—liver cancer	0.000213	0.000544	CcSEcCtD
Tramadol—Infection—Epirubicin—liver cancer	0.000213	0.000542	CcSEcCtD
Tramadol—Cough—Doxorubicin—liver cancer	0.000212	0.00054	CcSEcCtD
Tramadol—Shock—Epirubicin—liver cancer	0.000211	0.000537	CcSEcCtD
Tramadol—Convulsion—Doxorubicin—liver cancer	0.00021	0.000536	CcSEcCtD
Tramadol—Nervous system disorder—Epirubicin—liver cancer	0.00021	0.000535	CcSEcCtD
Tramadol—Thrombocytopenia—Epirubicin—liver cancer	0.00021	0.000535	CcSEcCtD
Tramadol—Hypertension—Doxorubicin—liver cancer	0.00021	0.000534	CcSEcCtD
Tramadol—Tachycardia—Epirubicin—liver cancer	0.000209	0.000533	CcSEcCtD
Tramadol—Skin disorder—Epirubicin—liver cancer	0.000208	0.00053	CcSEcCtD
Tramadol—Hyperhidrosis—Epirubicin—liver cancer	0.000207	0.000528	CcSEcCtD
Tramadol—Arthralgia—Doxorubicin—liver cancer	0.000207	0.000527	CcSEcCtD
Tramadol—Myalgia—Doxorubicin—liver cancer	0.000207	0.000527	CcSEcCtD
Tramadol—Chest pain—Doxorubicin—liver cancer	0.000207	0.000527	CcSEcCtD
Tramadol—Anxiety—Doxorubicin—liver cancer	0.000206	0.000525	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000205	0.000523	CcSEcCtD
Tramadol—Discomfort—Doxorubicin—liver cancer	0.000204	0.000521	CcSEcCtD
Tramadol—Anorexia—Epirubicin—liver cancer	0.000204	0.00052	CcSEcCtD
Tramadol—Dry mouth—Doxorubicin—liver cancer	0.000202	0.000515	CcSEcCtD
Tramadol—Hypotension—Epirubicin—liver cancer	0.0002	0.00051	CcSEcCtD
Tramadol—Confusional state—Doxorubicin—liver cancer	0.0002	0.000509	CcSEcCtD
Tramadol—Anaphylactic shock—Doxorubicin—liver cancer	0.000198	0.000505	CcSEcCtD
Tramadol—Infection—Doxorubicin—liver cancer	0.000197	0.000502	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000195	0.000497	CcSEcCtD
Tramadol—Shock—Doxorubicin—liver cancer	0.000195	0.000497	CcSEcCtD
Tramadol—Nervous system disorder—Doxorubicin—liver cancer	0.000194	0.000495	CcSEcCtD
Tramadol—Thrombocytopenia—Doxorubicin—liver cancer	0.000194	0.000495	CcSEcCtD
Tramadol—Insomnia—Epirubicin—liver cancer	0.000194	0.000494	CcSEcCtD
Tramadol—Tachycardia—Doxorubicin—liver cancer	0.000193	0.000493	CcSEcCtD
Tramadol—Skin disorder—Doxorubicin—liver cancer	0.000192	0.000491	CcSEcCtD
Tramadol—Paraesthesia—Epirubicin—liver cancer	0.000192	0.00049	CcSEcCtD
Tramadol—Hyperhidrosis—Doxorubicin—liver cancer	0.000192	0.000488	CcSEcCtD
Tramadol—Dyspnoea—Epirubicin—liver cancer	0.000191	0.000487	CcSEcCtD
Tramadol—Somnolence—Epirubicin—liver cancer	0.00019	0.000485	CcSEcCtD
Tramadol—Anorexia—Doxorubicin—liver cancer	0.000189	0.000482	CcSEcCtD
Tramadol—Dyspepsia—Epirubicin—liver cancer	0.000189	0.000481	CcSEcCtD
Tramadol—Decreased appetite—Epirubicin—liver cancer	0.000186	0.000475	CcSEcCtD
Tramadol—Hypotension—Doxorubicin—liver cancer	0.000185	0.000472	CcSEcCtD
Tramadol—Gastrointestinal disorder—Epirubicin—liver cancer	0.000185	0.000471	CcSEcCtD
Tramadol—Fatigue—Epirubicin—liver cancer	0.000185	0.000471	CcSEcCtD
Tramadol—Pain—Epirubicin—liver cancer	0.000183	0.000467	CcSEcCtD
Tramadol—Constipation—Epirubicin—liver cancer	0.000183	0.000467	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000181	0.00046	CcSEcCtD
Tramadol—Insomnia—Doxorubicin—liver cancer	0.000179	0.000457	CcSEcCtD
Tramadol—Paraesthesia—Doxorubicin—liver cancer	0.000178	0.000454	CcSEcCtD
Tramadol—Dyspnoea—Doxorubicin—liver cancer	0.000177	0.00045	CcSEcCtD
Tramadol—Feeling abnormal—Epirubicin—liver cancer	0.000176	0.00045	CcSEcCtD
Tramadol—Somnolence—Doxorubicin—liver cancer	0.000176	0.000449	CcSEcCtD
Tramadol—Gastrointestinal pain—Epirubicin—liver cancer	0.000175	0.000447	CcSEcCtD
Tramadol—Dyspepsia—Doxorubicin—liver cancer	0.000174	0.000445	CcSEcCtD
Tramadol—Decreased appetite—Doxorubicin—liver cancer	0.000172	0.000439	CcSEcCtD
Tramadol—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000171	0.000436	CcSEcCtD
Tramadol—Fatigue—Doxorubicin—liver cancer	0.000171	0.000436	CcSEcCtD
Tramadol—Urticaria—Epirubicin—liver cancer	0.00017	0.000434	CcSEcCtD
Tramadol—Pain—Doxorubicin—liver cancer	0.000169	0.000432	CcSEcCtD
Tramadol—Constipation—Doxorubicin—liver cancer	0.000169	0.000432	CcSEcCtD
Tramadol—Abdominal pain—Epirubicin—liver cancer	0.000169	0.000432	CcSEcCtD
Tramadol—Body temperature increased—Epirubicin—liver cancer	0.000169	0.000432	CcSEcCtD
Tramadol—Feeling abnormal—Doxorubicin—liver cancer	0.000163	0.000416	CcSEcCtD
Tramadol—Gastrointestinal pain—Doxorubicin—liver cancer	0.000162	0.000413	CcSEcCtD
Tramadol—Hypersensitivity—Epirubicin—liver cancer	0.000158	0.000402	CcSEcCtD
Tramadol—Urticaria—Doxorubicin—liver cancer	0.000157	0.000401	CcSEcCtD
Tramadol—Abdominal pain—Doxorubicin—liver cancer	0.000157	0.000399	CcSEcCtD
Tramadol—Body temperature increased—Doxorubicin—liver cancer	0.000157	0.000399	CcSEcCtD
Tramadol—Asthenia—Epirubicin—liver cancer	0.000154	0.000392	CcSEcCtD
Tramadol—Pruritus—Epirubicin—liver cancer	0.000152	0.000386	CcSEcCtD
Tramadol—Diarrhoea—Epirubicin—liver cancer	0.000147	0.000374	CcSEcCtD
Tramadol—Hypersensitivity—Doxorubicin—liver cancer	0.000146	0.000372	CcSEcCtD
Tramadol—Asthenia—Doxorubicin—liver cancer	0.000142	0.000362	CcSEcCtD
Tramadol—Dizziness—Epirubicin—liver cancer	0.000142	0.000361	CcSEcCtD
Tramadol—Pruritus—Doxorubicin—liver cancer	0.00014	0.000357	CcSEcCtD
Tramadol—Vomiting—Epirubicin—liver cancer	0.000136	0.000347	CcSEcCtD
Tramadol—Diarrhoea—Doxorubicin—liver cancer	0.000136	0.000346	CcSEcCtD
Tramadol—Rash—Epirubicin—liver cancer	0.000135	0.000344	CcSEcCtD
Tramadol—Dermatitis—Epirubicin—liver cancer	0.000135	0.000344	CcSEcCtD
Tramadol—Headache—Epirubicin—liver cancer	0.000134	0.000342	CcSEcCtD
Tramadol—Dizziness—Doxorubicin—liver cancer	0.000131	0.000334	CcSEcCtD
Tramadol—Nausea—Epirubicin—liver cancer	0.000127	0.000324	CcSEcCtD
Tramadol—Vomiting—Doxorubicin—liver cancer	0.000126	0.000321	CcSEcCtD
Tramadol—Rash—Doxorubicin—liver cancer	0.000125	0.000319	CcSEcCtD
Tramadol—Dermatitis—Doxorubicin—liver cancer	0.000125	0.000318	CcSEcCtD
Tramadol—Headache—Doxorubicin—liver cancer	0.000124	0.000317	CcSEcCtD
Tramadol—Nausea—Doxorubicin—liver cancer	0.000118	0.0003	CcSEcCtD
Tramadol—OPRM1—Signaling Pathways—KDR—liver cancer	1.89e-05	0.000212	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MAPK14—liver cancer	1.88e-05	0.000211	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—PIK3CA—liver cancer	1.86e-05	0.000208	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—RAF1—liver cancer	1.85e-05	0.000207	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—ESR1—liver cancer	1.85e-05	0.000207	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—PIK3CB—liver cancer	1.84e-05	0.000206	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IGF2—liver cancer	1.84e-05	0.000206	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—MTHFR—liver cancer	1.84e-05	0.000206	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—F2—liver cancer	1.82e-05	0.000204	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—PIK3CD—liver cancer	1.81e-05	0.000203	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—PIK3CB—liver cancer	1.8e-05	0.000202	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—MTOR—liver cancer	1.8e-05	0.000202	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PPARA—liver cancer	1.8e-05	0.000202	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—PIK3CA—liver cancer	1.8e-05	0.000201	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—SERPINE1—liver cancer	1.79e-05	0.000201	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PSMA4—liver cancer	1.79e-05	0.000201	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PSMD10—liver cancer	1.79e-05	0.000201	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—GSTM1—liver cancer	1.79e-05	0.0002	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—IL2—liver cancer	1.78e-05	0.0002	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—TERT—liver cancer	1.78e-05	0.000199	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—KRAS—liver cancer	1.78e-05	0.000199	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GSTA4—liver cancer	1.77e-05	0.000198	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PIK3CG—liver cancer	1.74e-05	0.000195	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—APC—liver cancer	1.74e-05	0.000195	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GOT2—liver cancer	1.74e-05	0.000195	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GSTA2—liver cancer	1.72e-05	0.000193	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—HRAS—liver cancer	1.72e-05	0.000193	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CSF2—liver cancer	1.72e-05	0.000192	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—RAF1—liver cancer	1.71e-05	0.000192	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—CYP1A1—liver cancer	1.69e-05	0.00019	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—H2AFX—liver cancer	1.69e-05	0.000189	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CDKN1B—liver cancer	1.69e-05	0.000189	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—IL2—liver cancer	1.69e-05	0.000189	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—AKT1—liver cancer	1.67e-05	0.000187	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—PIK3CB—liver cancer	1.67e-05	0.000187	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GSTA1—liver cancer	1.66e-05	0.000186	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CASP3—liver cancer	1.66e-05	0.000186	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—IL2—liver cancer	1.66e-05	0.000185	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—IL6—liver cancer	1.65e-05	0.000184	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—NAT2—liver cancer	1.64e-05	0.000184	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—BRAF—liver cancer	1.64e-05	0.000184	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CYP2E1—liver cancer	1.64e-05	0.000183	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—PIK3CA—liver cancer	1.63e-05	0.000183	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—KDR—liver cancer	1.63e-05	0.000182	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—RAF1—liver cancer	1.62e-05	0.000181	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MAPK14—liver cancer	1.62e-05	0.000181	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CCND1—liver cancer	1.61e-05	0.000181	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—JUN—liver cancer	1.61e-05	0.00018	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CTNNB1—liver cancer	1.6e-05	0.000179	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—ESR1—liver cancer	1.58e-05	0.000177	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—MTOR—liver cancer	1.58e-05	0.000177	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—PIK3CB—liver cancer	1.58e-05	0.000177	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—MTHFR—liver cancer	1.58e-05	0.000177	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ALDOB—liver cancer	1.58e-05	0.000176	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—MMP9—liver cancer	1.57e-05	0.000175	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—F2—liver cancer	1.57e-05	0.000175	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CDKN1A—liver cancer	1.56e-05	0.000175	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PPARA—liver cancer	1.55e-05	0.000173	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PIK3CG—liver cancer	1.54e-05	0.000173	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—IL2—liver cancer	1.54e-05	0.000172	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PIK3CD—liver cancer	1.53e-05	0.000172	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CYCS—liver cancer	1.53e-05	0.000172	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TERT—liver cancer	1.53e-05	0.000171	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—MAPK8—liver cancer	1.52e-05	0.000171	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—AKT1—liver cancer	1.52e-05	0.00017	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—PIK3CA—liver cancer	1.52e-05	0.00017	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—SERPINE1—liver cancer	1.52e-05	0.00017	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—HRAS—liver cancer	1.51e-05	0.000169	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GGT1—liver cancer	1.5e-05	0.000168	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GOT1—liver cancer	1.5e-05	0.000168	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CRABP1—liver cancer	1.5e-05	0.000168	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—KRAS—liver cancer	1.5e-05	0.000168	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—APC—liver cancer	1.5e-05	0.000168	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PIK3CG—liver cancer	1.5e-05	0.000168	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PPARG—liver cancer	1.49e-05	0.000167	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CDKN1B—liver cancer	1.48e-05	0.000166	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—AKT1—liver cancer	1.47e-05	0.000164	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CASP3—liver cancer	1.45e-05	0.000163	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—IL2—liver cancer	1.45e-05	0.000163	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—IL6—liver cancer	1.45e-05	0.000162	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CCND1—liver cancer	1.42e-05	0.000159	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—JUN—liver cancer	1.41e-05	0.000158	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—BRAF—liver cancer	1.41e-05	0.000158	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—VEGFA—liver cancer	1.41e-05	0.000158	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CTNNB1—liver cancer	1.4e-05	0.000157	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—KDR—liver cancer	1.4e-05	0.000157	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—STAT3—liver cancer	1.39e-05	0.000156	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MAPK14—liver cancer	1.39e-05	0.000156	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—PIK3CA—liver cancer	1.38e-05	0.000154	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—MMP9—liver cancer	1.37e-05	0.000154	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CDKN1A—liver cancer	1.37e-05	0.000153	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—RAF1—liver cancer	1.37e-05	0.000153	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—ESR1—liver cancer	1.36e-05	0.000153	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PIK3CD—liver cancer	1.36e-05	0.000152	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GSTP1—liver cancer	1.35e-05	0.000151	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—F2—liver cancer	1.35e-05	0.000151	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—ALB—liver cancer	1.34e-05	0.00015	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—MAPK8—liver cancer	1.34e-05	0.00015	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PIK3CB—liver cancer	1.34e-05	0.00015	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MTOR—liver cancer	1.34e-05	0.00015	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—AKT1—liver cancer	1.33e-05	0.000149	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—HMOX1—liver cancer	1.33e-05	0.000149	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PIK3CG—liver cancer	1.33e-05	0.000149	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PIK3CD—liver cancer	1.32e-05	0.000147	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—HPGDS—liver cancer	1.31e-05	0.000147	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—PIK3CA—liver cancer	1.3e-05	0.000146	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—SERPINE1—liver cancer	1.3e-05	0.000146	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—MYC—liver cancer	1.3e-05	0.000145	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—TGFB1—liver cancer	1.29e-05	0.000145	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—APC—liver cancer	1.29e-05	0.000144	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PIK3CG—liver cancer	1.29e-05	0.000144	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—KRAS—liver cancer	1.29e-05	0.000144	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PPARG—liver cancer	1.28e-05	0.000143	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—HRAS—liver cancer	1.28e-05	0.000143	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CDKN1B—liver cancer	1.25e-05	0.00014	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GSTM1—liver cancer	1.24e-05	0.000139	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—AKT1—liver cancer	1.24e-05	0.000139	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—VEGFA—liver cancer	1.23e-05	0.000138	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CASP3—liver cancer	1.23e-05	0.000138	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—IL2—liver cancer	1.23e-05	0.000137	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—STAT3—liver cancer	1.22e-05	0.000137	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—IL6—liver cancer	1.22e-05	0.000137	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—BRAF—liver cancer	1.21e-05	0.000136	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—KRAS—liver cancer	1.2e-05	0.000134	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CCND1—liver cancer	1.2e-05	0.000134	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—JUN—liver cancer	1.19e-05	0.000134	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CTNNB1—liver cancer	1.18e-05	0.000133	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—PIK3CA—liver cancer	1.18e-05	0.000133	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PIK3CB—liver cancer	1.18e-05	0.000132	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CYP1A1—liver cancer	1.18e-05	0.000132	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—RAF1—liver cancer	1.18e-05	0.000132	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PSMA4—liver cancer	1.17e-05	0.000131	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PSMD10—liver cancer	1.17e-05	0.000131	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PIK3CD—liver cancer	1.17e-05	0.000131	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MMP9—liver cancer	1.16e-05	0.00013	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CDKN1A—liver cancer	1.16e-05	0.00013	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—ALB—liver cancer	1.15e-05	0.000129	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MTOR—liver cancer	1.15e-05	0.000128	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PIK3CB—liver cancer	1.15e-05	0.000128	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GOT2—liver cancer	1.14e-05	0.000128	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—MYC—liver cancer	1.14e-05	0.000127	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PIK3CD—liver cancer	1.13e-05	0.000127	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—TGFB1—liver cancer	1.13e-05	0.000127	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MAPK8—liver cancer	1.13e-05	0.000126	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—AKT1—liver cancer	1.13e-05	0.000126	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—PIK3CA—liver cancer	1.12e-05	0.000126	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—SERPINE1—liver cancer	1.12e-05	0.000126	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—KRAS—liver cancer	1.11e-05	0.000124	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—PIK3CA—liver cancer	1.1e-05	0.000123	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—MTHFR—liver cancer	1.1e-05	0.000123	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—HRAS—liver cancer	1.1e-05	0.000123	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CDKN1B—liver cancer	1.08e-05	0.000121	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PPARA—liver cancer	1.08e-05	0.000121	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CYP2E1—liver cancer	1.07e-05	0.00012	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—AKT1—liver cancer	1.07e-05	0.000119	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—TP53—liver cancer	1.06e-05	0.000119	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CASP3—liver cancer	1.06e-05	0.000118	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IL2—liver cancer	1.05e-05	0.000118	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—KRAS—liver cancer	1.05e-05	0.000117	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—IL6—liver cancer	1.05e-05	0.000117	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—VEGFA—liver cancer	1.04e-05	0.000117	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—STAT3—liver cancer	1.03e-05	0.000116	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CCND1—liver cancer	1.03e-05	0.000115	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—JUN—liver cancer	1.03e-05	0.000115	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—PIK3CA—liver cancer	1.02e-05	0.000114	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CTNNB1—liver cancer	1.02e-05	0.000114	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—HRAS—liver cancer	1.02e-05	0.000114	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PIK3CB—liver cancer	1.02e-05	0.000114	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—RAF1—liver cancer	1.01e-05	0.000113	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CYCS—liver cancer	1e-05	0.000112	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MMP9—liver cancer	9.98e-06	0.000112	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CDKN1A—liver cancer	9.94e-06	0.000111	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MTOR—liver cancer	9.88e-06	0.000111	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PIK3CB—liver cancer	9.88e-06	0.000111	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GGT1—liver cancer	9.84e-06	0.00011	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GOT1—liver cancer	9.84e-06	0.00011	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—IL6—liver cancer	9.74e-06	0.000109	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MAPK8—liver cancer	9.7e-06	0.000109	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—AKT1—liver cancer	9.68e-06	0.000108	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—PIK3CA—liver cancer	9.64e-06	0.000108	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MYC—liver cancer	9.6e-06	0.000107	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—TGFB1—liver cancer	9.57e-06	0.000107	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—HRAS—liver cancer	9.43e-06	0.000106	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—TP53—liver cancer	9.33e-06	0.000104	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CDKN1B—liver cancer	9.27e-06	0.000104	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PIK3CG—liver cancer	9.22e-06	0.000103	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—AKT1—liver cancer	9.17e-06	0.000103	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CASP3—liver cancer	9.09e-06	0.000102	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IL2—liver cancer	9.08e-06	0.000102	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—IL6—liver cancer	9.03e-06	0.000101	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—AKT1—liver cancer	8.98e-06	0.000101	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—VEGFA—liver cancer	8.96e-06	0.0001	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—HRAS—liver cancer	8.92e-06	9.99e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PPARG—liver cancer	8.9e-06	9.96e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—STAT3—liver cancer	8.87e-06	9.93e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—KRAS—liver cancer	8.87e-06	9.93e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CCND1—liver cancer	8.85e-06	9.9e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GSTP1—liver cancer	8.84e-06	9.89e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—JUN—liver cancer	8.83e-06	9.88e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CTNNB1—liver cancer	8.76e-06	9.81e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—HMOX1—liver cancer	8.71e-06	9.76e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MMP9—liver cancer	8.59e-06	9.62e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CDKN1A—liver cancer	8.56e-06	9.58e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—IL6—liver cancer	8.54e-06	9.56e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MAPK8—liver cancer	8.35e-06	9.35e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—AKT1—liver cancer	8.33e-06	9.33e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MYC—liver cancer	8.24e-06	9.23e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—TGFB1—liver cancer	8.22e-06	9.2e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PIK3CA—liver cancer	8.15e-06	9.12e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GSTM1—liver cancer	8.12e-06	9.09e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PIK3CD—liver cancer	8.11e-06	9.08e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—ALB—liver cancer	8e-06	8.96e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—TP53—liver cancer	7.88e-06	8.82e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—AKT1—liver cancer	7.88e-06	8.82e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—VEGFA—liver cancer	7.71e-06	8.63e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CYP1A1—liver cancer	7.7e-06	8.62e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—STAT3—liver cancer	7.64e-06	8.55e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—KRAS—liver cancer	7.62e-06	8.53e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—HRAS—liver cancer	7.54e-06	8.44e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—IL6—liver cancer	7.21e-06	8.08e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PIK3CA—liver cancer	7.2e-06	8.07e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—MTHFR—liver cancer	7.18e-06	8.03e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MYC—liver cancer	7.1e-06	7.94e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TGFB1—liver cancer	7.08e-06	7.92e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PIK3CB—liver cancer	7.07e-06	7.91e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PPARA—liver cancer	7.04e-06	7.88e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PIK3CA—liver cancer	7e-06	7.83e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—TP53—liver cancer	6.77e-06	7.58e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—AKT1—liver cancer	6.66e-06	7.45e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—KRAS—liver cancer	6.56e-06	7.34e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—HRAS—liver cancer	6.47e-06	7.25e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PIK3CA—liver cancer	6.2e-06	6.94e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IL6—liver cancer	6.2e-06	6.94e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PIK3CG—liver cancer	6.03e-06	6.75e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PIK3CA—liver cancer	6.02e-06	6.74e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—AKT1—liver cancer	5.89e-06	6.59e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TP53—liver cancer	5.83e-06	6.52e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PPARG—liver cancer	5.82e-06	6.51e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—AKT1—liver cancer	5.72e-06	6.4e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—HRAS—liver cancer	5.57e-06	6.24e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IL6—liver cancer	5.33e-06	5.97e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PIK3CD—liver cancer	5.3e-06	5.93e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ALB—liver cancer	5.23e-06	5.86e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—AKT1—liver cancer	5.06e-06	5.67e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—AKT1—liver cancer	4.92e-06	5.51e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PIK3CB—liver cancer	4.62e-06	5.17e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PIK3CA—liver cancer	4.31e-06	4.82e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—AKT1—liver cancer	3.52e-06	3.94e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PIK3CA—liver cancer	2.82e-06	3.15e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—AKT1—liver cancer	2.3e-06	2.58e-05	CbGpPWpGaD
